Xenon Pharmaceuticals, Inc. (XENE)

43.79 +1.24 (+2.91%) USD  |  NASDAQ  |  Mar 03, 16:00
44.10 +0.31 (+0.71%) Pre-Market: 08:48
More

Xenon Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for XENE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Aurinia Pharmaceuticals, Inc. --
Oncolytics Biotech, Inc. --
Edesa Biotech, Inc. --
Lexaria Bioscience Corp. --
ProMIS Neurosciences, Inc. --